Pancreatic Cancer Research

ResearcherYokohama City UniversityNo recent work listed

Maeda Shin

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper

Papers 1

  1. Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study. Last author DOI 10.1016/j.pan.2022.06.004↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuhei Nagashima · 1 shared paper, 2022 · strength 0.15
  2. Satoshi Kobayashi · 1 shared paper, 2022 · strength 0.15
  3. Manabu Morimoto · 1 shared paper, 2022 · strength 0.15
  4. Shun Tezuka · 1 shared paper, 2022 · strength 0.15
  5. Makoto Ueno · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.